Literature DB >> 1347513

Over-expression of p53 nuclear oncoprotein in colorectal adenomas.

M Pignatelli1, G W Stamp, G Kafiri, D Lane, W F Bodmer.   

Abstract

p53 is a nuclear phosphoprotein which controls normal cell growth. Normal p53 protein is undetectable by standard immunohistochemical staining and the over-expression found in neoplastic cells correlates with the presence of point mutations of evolutionary conserved regions of the p53 gene. We examined the expression of p53 protein in a series of 36 colorectal adenomas (13 tubular, 17 tubulovillous, 6 villous) showing different degrees of dysplasia (11 mild, 19 moderate, 6 severe), 11 moderately differentiated adenocarcinomas (6 Duke's A, 4 Duke's B, 1 Duke's C) and 5 metaplastic polyps using the polyclonal antibody CM1 which recognises p53 protein in conventionally fixed and processed histological material. We found that 15 out of 36 colorectal adenomas showed p53 immunoreactivity, although in 4 positive cases (26%) the staining was very focal (less than 0.1% positive cells). More than 80% of severely dysplastic adenomas showed strong p53 immunoreactivity and this over-expression was correlated with increased cell proliferative rate as detected by the proliferating-cell-nuclear-antigen (PCNA) staining. p53 nuclear staining was also seen in 8 out of 11 (65%) colorectal adenocarcinomas as previously shown. Our data suggest that the p53 gene mutation, with the subsequent over-expression of the protein, occurs in colorectal adenomas and may therefore be a fundamental genetic event underlying the dysplasia and loss of proliferative control that are characteristic of adenomas with malignant potential.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347513     DOI: 10.1002/ijc.2910500503

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Expression of proliferating cell nuclear antigen in polyps from large intestine.

Authors:  Yu-Qin Luo; Lian-Sheng Ma; Yi-Ling Zhao; Kai-Chun Wu; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

2.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

3.  Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence.

Authors:  R H Hardwick; N A Shepherd; M Moorghen; P V Newcomb; D Alderson
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

4.  Accumulation of p53 protein in inverted transitional cell papilloma of the urinary bladder.

Authors:  K W Chan; K Y Lam; G Srivastava
Journal:  Clin Mol Pathol       Date:  1996-02

5.  Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas.

Authors:  S Ieda; M Watatani; T Yoshida; K Kuroda; H Inui; M Yasutomi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  Expression of proliferating cell nuclear antigen in hyperplastic polyps, adenomas and inflammatory cloacogenic polyps of the large intestine.

Authors:  N J Carr; J M Monihan; U C Nzeako; L A Murakata; L H Sobin
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

7.  Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.

Authors:  X P Hao; T Günther; A Roessner; A B Price; I C Talbot
Journal:  Mol Pathol       Date:  1998-02

8.  The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma.

Authors:  G U Auer; K M Heselmeyer; R G Steinbeck; E Munck-Wikland; A D Zetterberg
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Multiple biomarkers of colorectal tumor in a differential diagnosis model: a quantitative study.

Authors:  Wen Jin; Mei-Qin Gao; Zhi-Wu Lin; Dai-Xing Yang
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

10.  p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan.

Authors:  For-Wey Lung; Tai-Min Lee; Bih-Ching Shu; Fu-Hsin Chang
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-07       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.